Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Hikal Limited (HIKAL.BO)

Compare
433.05
+18.65
+(4.50%)
At close: 3:40:12 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Jai Vishwanath Hiremath Founder & Executive Chairman 52.83M -- 1948
Mr. Sameer Jai Hiremath MD & Executive Director 47.9M -- 1974
Mr. Rajasekhar Reddy Chintakindi Company Secretary & Compliance Officer -- -- --
Mr. Anish Dilip Swadi Senior President of Animal Health & Business Transformation -- -- --
Mr. Kuldeep Jain Chief Financial Officer -- -- --

Hikal Limited

Great Eastern Chambers
6th Floor Sector 11 C.B.D. Belapur
Navi Mumbai, 400614
India
91 22 6277 0299 https://www.hikal.com
Sector: 
Healthcare
Full Time Employees: 
2,061

Description

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Corporate Governance

Hikal Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

Hikal Limited Earnings Date

Recent Events

February 7, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers